1-6 of 6
Yann Nouet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Using Single Cell Multi-Omic Clonal Tracking in SMM to Identify Clones That Progress to MM and Harbor Treatment Resistance Features

Adam Sciambi, Daniel Mendoza, Indira Krishnan, Joanne Nguyen, Lubna Nousheen, Benjamin Geller, Cedric Dos Santos, Vivek S. Chopra, Habib Hamidi, Michael Nixon, Yann Nouet, Todd E. Druley, Herve Avet-Loiseau
Journal: Blood
Blood (2024) 144 (Supplement 1): 4722.
https://doi.org/10.1182/blood-2024-205533
Published: 2024
Journal Articles

Single Cell Multi-Omic Correlation of Single Nucleotide Variants, Copy Number Variation and Surface Epitopes for Clonal Profiling of Myeloma

Adam Sciambi, Cedric Dos Santos, Yang Li, Joanne Bio Nguyen, Priyam Priyam, Vivek Chopra, Habib Hamidi, Michael Nixon, Yann Nouet, Todd E. Druley, Herve Avet-Loiseau
Journal: Blood
Blood (2023) 142 (Supplement 1): 4714.
https://doi.org/10.1182/blood-2023-189518
Published: 2023
Journal Articles

Cytokine Release Syndrome: The Patient, Caregiver and Healthcare Professional Experience

Janelle Soong, Giuseppe De Carlo, Naziah Lasi-Tejani, Sumanjit K. Sethi, Natacha Bolaños, Martine Elias, Yelak Biru, Solène Clavreul, G. Scott Chandler, Klaus Finzler, Yann Nouet, Antonio Giuseppe Del Santo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3718.
https://doi.org/10.1182/blood-2023-174207
Published: 2023
Journal Articles

CO43923: A Platform Study Evaluating the Safety and Efficacy of Multiple Treatment Combinations in Patients with Multiple Myeloma

Semira Sheikh, Upen Patil, Kristin Wehrman, Elissavet Sideri, Shannon M. Ruppert, Yanke Yu, Mark Yan, Jasdeep Bhatti, Lydia Pogeza, Yann Nouet
Journal: Blood
Blood (2022) 140 (Supplement 1): 12640–12641.
https://doi.org/10.1182/blood-2022-157737
Published: 2022
Journal Articles

Biomarker Analysis of a Phase Ia/Ib Open-Label, Multicentre Study of Tiragolumab or Tiragolumab + Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)

Shannon Ruppert, Vaikunth Cuchelkar, Raymond Meng, Eunpi Cho, Sean Lear, Cheryl Victoria Wong, Aparna Raval, Yann Nouet
Journal: Blood
Blood (2021) 138 (Supplement 1): 1337.
https://doi.org/10.1182/blood-2021-147773
Published: 2021
Journal Articles

Combination of Idasanutlin, Venetoclax and Obinutuzumab in Patients with Relapsed or Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Results from a Phase I/II Study

Manali Kamdar, MD, Bradley Augustson, MBBS FRACP FRCPA, Young Rok Do, PhDMD, James Edwards, Mark Hertzberg, MBBS PhDFRACP FRCPA, Amanda Johnston, FRACP,FRCPA,MBBS,BMBS,MD, Jin Seok Kim, MD PhD, Frank P. Kroschinsky, MDMBA, Sonali M. Smith, MD, Don A. Stevens, MD, Annabelle Monnet, Ye Zhao, Yann Nouet, PhD MSc, Viktoriya Marinova
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-136221
Published: 2020